Once a medicine has been released on the market, physicians, patients, healthcare teams and other caregivers can report side effects and safety concerns. These can either be reported to Teva directly or to the local authorities. All Teva employees attend a pharmacovigilance training course, to ensure effective collection of safety data within our organization.
Additionally, Teva takes active measures to analyze all collected safety data:
Signal Detection- A periodic review, whereby the safety profile of each product is analyzed and evaluated to identify any possible new safety issues
Periodic Safety Update Report- A comprehensive report submitted to the authorities that includes safety data and analysis of risk-benefit profile
Risk Management Plan- Based on a specific product’s safety profile, Teva suggests additional activities to monitor, minimize or prevent identified and potential risks and adverse events
We encourage patients and caregivers to contact us or their physicians if they experience any side effect that might be related to one of our medicines. Local contact information can be found on many of our medicine packages.